Cancer and Blood Disorders Programs at Arkansas Children’s  (Hematology and Oncology)

Arkansas Children's Cancer and Blood Disorders Program is the only pediatric cancer treatment program in Arkansas. Our experienced team sees nearly 7,000 patients each year. At any given time, more than 250 patients are being treated for cancer or blood disorders here. If your child’s condition is difficult to cure or does not respond to traditional therapies, we are ready and prepared to offer new techniques and clinical trials, providing the skill and experience necessary to treat the most complex cases.

Surround Your Child with Expert Care

Our expert doctors and care teams are highly skilled in the diagnosis, evaluation, and treatment of childhood problems related to blood and tumors, such as:

• Anemia
• Bone tumors
• Brain and spinal cord tumors
• Germ cell tumors
• Hemophilia and bleeding disorders
• Histiocytosis
• Leukemia
• Liver tumors
• Lymphoma - Hodgkin and Non-Hodgkin Lymphoma
• Neuroblastoma
• Other malignant diseases
• Sickle cell disease
• Soft-tissue sarcomas
• Solid tumors
• Thrombocytopenia

A Leader in Cancer Research and Family Support

Arkansas Children's is a member of several groups dedicated to improving the lives of children and families living with cancer and blood disorders. Membership in these groups lets your child receive cutting-edge treatments and take part in clinical trials.

• Children's Oncology Group (COG). COG provides information and support to help children and their families in the fight against cancer.
• Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC). POETIC is a group of 10 large academic medical centers in North America with a major emphasis on comprehensive cancer care and research.
• Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC). The NMTRC is a group of 25 universities and children’s hospitals that create a nationwide network of childhood cancer clinical trials. These trials are developing novel therapies for high-risk neuroblastoma and medulloblastoma.

Pediatric Blood and Marrow Transplant (BMT-CT)

Arkansas Children’s Hospital offers both allogeneic (relative or unrelated donor) and autologous (self-donor) blood marrow transplants to treat cancers, immune disorders and blood diseases. BMT uses healthy bone marrow to replace damaged or destroyed bone marrow.

Our program is also a certified CAR-T site. Chimeric antigen receptor (CAR) T cells use the patient’s own modified T cells to attack and kill cancer cells. This therapy is used to treat some of the most challenging pediatric cancers, including B-cell acute lymphoblastic leukemia (ALL).

Turning Cancer Survivorship into Thrivership

Arkansas Children’s understands that a cancer diagnosis changes the lives of patients and their families. The THRIVE clinic at Arkansas Children’s Hospital is the state’s only survivorship clinic for children with cancer. It offers a multidisciplinary team to help children and families navigate life for up to 10 years after treatment ends.

In addition to medical challenges, the program addresses mental health concerns, learning difficulties, social reintegration challenges and fears of relapse. Integrated treatments ensure patients go beyond surviving cancer — they THRIVE.